These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 26314341)
21. Association between SCN1A polymorphism and carbamazepine-resistant epilepsy. Abe T; Seo T; Ishitsu T; Nakagawa T; Hori M; Nakagawa K Br J Clin Pharmacol; 2008 Aug; 66(2):304-7. PubMed ID: 18489610 [TBL] [Abstract][Full Text] [Related]
22. Comprehensive analysis of the association of SCN1A gene polymorphisms with the retention rate of carbamazepine following monotherapy for new-onset focal seizures in the Chinese Han population. Zhou BT; Zhou QH; Yin JY; Li GL; Xu XJ; Qu J; Liu D; Zhou HH; Liu ZQ Clin Exp Pharmacol Physiol; 2012 Apr; 39(4):379-84. PubMed ID: 22292851 [TBL] [Abstract][Full Text] [Related]
23. Association of EPHX1 polymorphisms with plasma concentration of carbamazepine in epileptic patients: Systematic review and meta-analysis. Hu T; Zeng X; Tian T; Liu J J Clin Neurosci; 2021 Sep; 91():159-171. PubMed ID: 34373022 [TBL] [Abstract][Full Text] [Related]
24. Population pharmacokinetic modelling of carbamazepine in epileptic elderly patients: implications for dosage. Bondareva IB; Jelliffe RW; Gusev EI; Guekht AB; Melikyan EG; Belousov YB J Clin Pharm Ther; 2006 Jun; 31(3):211-21. PubMed ID: 16789986 [TBL] [Abstract][Full Text] [Related]
25. Effects of SCN1A and GABA receptor genetic polymorphisms on carbamazepine tolerability and efficacy in Chinese patients with partial seizures: 2-year longitudinal clinical follow-up. Zhou BT; Zhou QH; Yin JY; Li GL; Qu J; Xu XJ; Liu D; Zhou HH; Liu ZQ CNS Neurosci Ther; 2012 Jul; 18(7):566-72. PubMed ID: 22591328 [TBL] [Abstract][Full Text] [Related]
26. Effect of CYP3A5 genotypes on the pharmacokinetics of carbamazepine when used as monotherapy or co-administered with phenytoin, phenobarbital or valproic acid in Thai patients. Panomvana D; Traiyawong T; Towanabut S J Pharm Pharm Sci; 2013; 16(4):502-10. PubMed ID: 24210059 [TBL] [Abstract][Full Text] [Related]
27. Different EPHX1 methylation levels in promoter area between carbamazepine-resistant epilepsy group and carbamazepine-sensitive epilepsy group in Chinese population. Lv Y; Zheng X; Shi M; Wang Z; Cui L BMC Neurol; 2019 Jun; 19(1):114. PubMed ID: 31164100 [TBL] [Abstract][Full Text] [Related]
28. Influence of cytochrome P450 3A5 (CYP3A5) genetic polymorphism on dose-adjusted plasma levels of carbamazepine in epileptic patients in South Indian population. Ganesapandian M; Ramasamy K; Adithan S; Narayan SK Indian J Pharmacol; 2019; 51(6):384-388. PubMed ID: 32029960 [TBL] [Abstract][Full Text] [Related]
29. Effects of CYP3A5 and UGT2B7 variants on steady-state carbamazepine concentrations in Chinese epileptic patients. Lu Q; Huang YT; Shu Y; Xu P; Xiang DX; Qu Q; Qu J Medicine (Baltimore); 2018 Jul; 97(30):e11662. PubMed ID: 30045320 [TBL] [Abstract][Full Text] [Related]
30. Slow carbamazepine clearance in a nonadherent Malay woman with epilepsy and thyrotoxicosis. Yeap LL; Lim KS; Ng CC; Hui-Ping Khor A; Lo YL Ther Drug Monit; 2014 Feb; 36(1):3-9. PubMed ID: 24342894 [TBL] [Abstract][Full Text] [Related]
31. Comparison of oxcarbazepine efficacy and MHD concentrations relative to age and BMI: Associations among ABCB1, ABCC2, UGT2B7, and SCN2A polymorphisms. Yang X; Yan Y; Fang S; Zeng S; Ma H; Qian L; Chen X; Wei J; Gong Z; Xu Z Medicine (Baltimore); 2019 Mar; 98(12):e14908. PubMed ID: 30896644 [TBL] [Abstract][Full Text] [Related]
32. ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients. Seo T; Ishitsu T; Ueda N; Nakada N; Yurube K; Ueda K; Nakagawa K Pharmacogenomics; 2006 Jun; 7(4):551-61. PubMed ID: 16753003 [TBL] [Abstract][Full Text] [Related]
33. Linkage disequilibrium between polymorphisms of ABCB1 and ABCC2 to predict the treatment outcome of Malaysians with complex partial seizures on treatment with carbamazepine mono-therapy at the Kuala Lumpur Hospital. Subenthiran S; Abdullah NR; Joseph JP; Muniandy PK; Mok BT; Kee CC; Ismail Z; Mohamed Z PLoS One; 2013; 8(5):e64827. PubMed ID: 23717663 [TBL] [Abstract][Full Text] [Related]
34. Association of xenobiotic receptor polymorphisms with carbamazepine response in epilepsy patients. Kong FC; Ma CL; Lang LQ; Zhong MK Gene; 2021 Mar; 771():145359. PubMed ID: 33333223 [TBL] [Abstract][Full Text] [Related]
35. Haplotype structures of EPHX1 and their effects on the metabolism of carbamazepine-10,11-epoxide in Japanese epileptic patients. Nakajima Y; Saito Y; Shiseki K; Fukushima-Uesaka H; Hasegawa R; Ozawa S; Sugai K; Katoh M; Saitoh O; Ohnuma T; Kawai M; Ohtsuki T; Suzuki C; Minami N; Kimura H; Goto Y; Kamatani N; Kaniwa N; Sawada J Eur J Clin Pharmacol; 2005 Mar; 61(1):25-34. PubMed ID: 15692831 [TBL] [Abstract][Full Text] [Related]
36. Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin. Tate SK; Depondt C; Sisodiya SM; Cavalleri GL; Schorge S; Soranzo N; Thom M; Sen A; Shorvon SD; Sander JW; Wood NW; Goldstein DB Proc Natl Acad Sci U S A; 2005 Apr; 102(15):5507-12. PubMed ID: 15805193 [TBL] [Abstract][Full Text] [Related]
37. Presence of allele CYP3A4*16 does not have any bearing on carbamazepine-induced adverse drug reactions in North Indian people with epilepsy. Garg VK; Goyal MK; Khullar M; Saikia B; Medhi B; Prakash A; Prabhat N; Tandyala N; Mahesh KV; Kharbanda PS; Prabhakar S; Modi M; Lal V; Shree R; Sachdeva J Indian J Pharmacol; 2020; 52(5):378-382. PubMed ID: 33283769 [TBL] [Abstract][Full Text] [Related]
38. The lack of influence of IVS5-91 G>A polymorphism of the SCN1A gene on efficacy of lamotrigine in patients with focal epilepsy. Markovic I; Pejanovic-Skobic N; Bozina N; Susak Sporis I; Sporis D; Basic S Neurol Res; 2019 Oct; 41(10):930-935. PubMed ID: 31256750 [No Abstract] [Full Text] [Related]
39. Pregnane X receptor and hepatocyte nuclear factor 4α polymorphisms are cooperatively associated with carbamazepine autoinduction. Saruwatari J; Yoshida S; Tsuda Y; Okada Y; Ogusu N; Yoshida K; Oniki K; Yasui-Furukori N; Kaneko S; Ishitsu T; Nakagawa K Pharmacogenet Genomics; 2014 Mar; 24(3):162-71. PubMed ID: 24384557 [TBL] [Abstract][Full Text] [Related]
40. A functional polymorphism in the SCN1A gene does not influence antiepileptic drug responsiveness in Italian patients with focal epilepsy. Manna I; Gambardella A; Bianchi A; Striano P; Tozzi R; Aguglia U; Beccaria F; Benna P; Campostrini R; Canevini MP; Condino F; Durisotti C; Elia M; Giallonardo AT; Iudice A; Labate A; La Neve A; Michelucci R; Muscas GC; Paravidino R; Zaccara G; Zucca C; Zara F; Perucca E Epilepsia; 2011 May; 52(5):e40-4. PubMed ID: 21561445 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]